Trial intelligence / Profile preview

Intra-Oral Ketoprofen Gel for Migraine Prevention

NCT01211795Phase 3Completed

Start
Oct 2009
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Ketofen in migraine. Started Oct 2009; status: completed.

02

Drugs

Ketofen
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01211795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01211795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call